EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking and Molecular Dynamics to Find New SigB Inhibitors Against Staphylococcus Aureus

A.K. Hasan, W.A.H. Al-Daraghi

Лабораторная диагностика. Восточная Европа · 30.09.2026 · 15 (3(S)) · 31-43

DOI: 10.34883/pi.2026.15.3.047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Лабораторная диагностика. Восточная Европа, online erschienen am 30.09.2026. Verfasst von A.K. Hasan und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Staphylococcus aureus is a clinically important opportunistic pathogen capable of regulating virulence and establishing persistent infections. Targeting the alternative sigma factor B (SigB), a global stress-response regulator, represents a promising anti-virulence strategy for controlling pathogenic bacteria.

Purpose

To identify novel SigB inhibitors through a comprehensive in silico approach and evaluate their potential as anti-virulence agents against S. aureus. Materials and methods. Virtual screening of more than 240,000 compounds from the NPASS, MolPort, and Natural Atlas databases was conducted against the SigB crystal structure (PDB ID: 8X6G) using PyRx v1.2 and AutoDock Vina v1.2.7. The top six compounds were further evaluated through 100 ns molecular dynamics simulations using GROMACS v2022.6. Drug-likeness and pharmacokinetic properties were assessed using ADMET prediction tools.

Results

Six high-affinity ligands were identified, with Ligand 6 and Ligand 1 exhibiting the strongest binding affinities of –9.3 and –9.1 kcal/mol, respectively. Molecular dynamics analyses demonstrated stable protein-ligand complexes, particularly for Ligand 6, as evidenced by favorable RMSD, RMSF, and radius of gyration (Rg) values. Stable interactions with key SigB residues, including LYS120 and TYR160, were maintained throughout the simulation. ADMET analysis predicted favorable drug-like and pharmacokinetic properties for the selected compounds.

Conclusion

The findings highlight SigB as a promising anti-virulence target in S. aureus. The identified ligands, particularly Ligand 6, represent potential lead compounds for the development of novel anti-virulence therapeutics and warrant further experimental validation.

Zitieren

APA

Hasan, A., & Al-Daraghi, W. (2026). Molecular Docking and Molecular Dynamics to Find New SigB Inhibitors Against Staphylococcus Aureus. Лабораторная диагностика. Восточная Европа, 15(3(S)), 31-43. https://doi.org/10.34883/pi.2026.15.3.047

Vancouver

Hasan A, Al-Daraghi W. Molecular Docking and Molecular Dynamics to Find New SigB Inhibitors Against Staphylococcus Aureus. Лабораторная диагностика. Восточная Европа. 2026;15(3(S)):31-43. doi:10.34883/pi.2026.15.3.047

BibTeX
@article{Hasan2026,
  author = {Hasan, A.K. and Al-Daraghi, W.A.H.},
  title = {Molecular Docking and Molecular Dynamics to Find New SigB Inhibitors Against Staphylococcus Aureus},
  journal = {Лабораторная диагностика. Восточная Европа},
  year = {2026},
  volume = {15},
  number = {3(S)},
  pages = {31--43},
  doi = {10.34883/pi.2026.15.3.047}
}
Kostenlos starten →